Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vera Ehrenstein

Showing results (161-170 of 176) with videos related to

Pageof 18
Sort By:
Drug Safety|April 26, 2023
Prenatal exposure to pregabalin, birth outcomes and neurodevelopment - a population-based cohort study in four Nordic countriesElena Dudukina, Szimonetta Komjáthiné Szépligeti, Pär Karlsson, et al.
Clinical Epidemiology|August 9, 2016
Design and methods for a Scandinavian pharmacovigilance study of osteonecrosis of the jaw and serious infections among cancer patients treated with antiresorptive agents for the prevention of skeletal-related eventsJohn Acquavella, Vera Ehrenstein, Morten Schiødt, et al.
Pharmacoepidemiology and Drug Safety|December 10, 2022
Validation of safety outcomes in routinely collected data: Lessons learned from a multinational postapproval safety studyPatrick J Arena, Kui Huang, Lukas Löfling, et al.
American Journal of Industrial Medicine|November 19, 2009
Occupational health crossing borders part 2: Comparison of 18 occupational health systems across the globeKatja Radon, Vera Ehrenstein, Dennis Nowak, et al.
Pharmacoepidemiology and Drug Safety|January 11, 2021
Outcomes in patients with lung cancer treated with crizotinib and erlotinib in routine clinical practice: A post-authorization safety cohort study conducted in Europe and in the United StatesVera Ehrenstein, Kui Huang, Johnny Kahlert, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 26, 2019
Sinéad M Langan, Sigrún A J Schmidt, Kevin Wing, et al.
BMJ (Clinical Research Ed.)|November 16, 2018
The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)Sinéad M Langan, Sigrún Aj Schmidt, Kevin Wing, et al.
Clinical Epidemiology|March 27, 2026
Harmonizing Case Validation for Vaccine Safety in Real-World Data: The VAC4EU ExperienceAmirreza Dehghan Tarazjani, Daniel Weibel, Taylor Aurelius, et al.
Vaccines|July 30, 2025
Clinical Course, Outcomes, and Risk Factors of Myocarditis and Pericarditis Following Administration of mRNA-1273 Vaccination: A Protocol for a Federated Real-World Evidence Vaccine Safety Study Using Data from Five European Data SourcesLaura C Zwiers, Diederick E Grobbee, Rob Schneijdenberg, et al.
Pharmacoepidemiology and Drug Safety|June 28, 2021
Use of intravenous iron and risk of anaphylaxis: A multinational observational post-authorisation safety study in EuropeJoan Fortuny, Gero von Gersdorff, Régis Lassalle, et al.
Pageof 18

Showing results (161-170 of 176) with videos related to

Sort By:
Pageof 18
Drug Safety|April 26, 2023
Prenatal exposure to pregabalin, birth outcomes and neurodevelopment - a population-based cohort study in four Nordic countriesElena Dudukina, Szimonetta Komjáthiné Szépligeti, Pär Karlsson, et al.
Clinical Epidemiology|August 9, 2016
Design and methods for a Scandinavian pharmacovigilance study of osteonecrosis of the jaw and serious infections among cancer patients treated with antiresorptive agents for the prevention of skeletal-related eventsJohn Acquavella, Vera Ehrenstein, Morten Schiødt, et al.
Pharmacoepidemiology and Drug Safety|December 10, 2022
Validation of safety outcomes in routinely collected data: Lessons learned from a multinational postapproval safety studyPatrick J Arena, Kui Huang, Lukas Löfling, et al.
American Journal of Industrial Medicine|November 19, 2009
Occupational health crossing borders part 2: Comparison of 18 occupational health systems across the globeKatja Radon, Vera Ehrenstein, Dennis Nowak, et al.
Pharmacoepidemiology and Drug Safety|January 11, 2021
Outcomes in patients with lung cancer treated with crizotinib and erlotinib in routine clinical practice: A post-authorization safety cohort study conducted in Europe and in the United StatesVera Ehrenstein, Kui Huang, Johnny Kahlert, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 26, 2019
Sinéad M Langan, Sigrún A J Schmidt, Kevin Wing, et al.
BMJ (Clinical Research Ed.)|November 16, 2018
The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)Sinéad M Langan, Sigrún Aj Schmidt, Kevin Wing, et al.
Clinical Epidemiology|March 27, 2026
Harmonizing Case Validation for Vaccine Safety in Real-World Data: The VAC4EU ExperienceAmirreza Dehghan Tarazjani, Daniel Weibel, Taylor Aurelius, et al.
Vaccines|July 30, 2025
Clinical Course, Outcomes, and Risk Factors of Myocarditis and Pericarditis Following Administration of mRNA-1273 Vaccination: A Protocol for a Federated Real-World Evidence Vaccine Safety Study Using Data from Five European Data SourcesLaura C Zwiers, Diederick E Grobbee, Rob Schneijdenberg, et al.
Pharmacoepidemiology and Drug Safety|June 28, 2021
Use of intravenous iron and risk of anaphylaxis: A multinational observational post-authorisation safety study in EuropeJoan Fortuny, Gero von Gersdorff, Régis Lassalle, et al.
Pageof 18